AnsellFRA:PD1 +0.73%76 Days Payable is 83.72 as of Dec. 2025, which is 9% above its 10-year median of 77.01. GuruFocus rates FRA:PD1 with a GF Score™ of 76/100 and a GF Value™ of €63.91. The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Ansell ranks better than 61.13% on this metric.
Ansell's average Accounts Payable for the
six
months ended in Dec. 2025 was €237 Mil. Ansell's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €517 Mil.
Hence, Ansell's Days Payable for the
six
months ended in Dec. 2025 was 83.72.
The historical rank and industry rank for Ansell's Days Payable or its related term are showing as below:
FRA:PD1'
s Days Payable Range Over the Past 10 Years
Min: 70.61 Med: 77.01 Max: 91.39
Current: 91.39
During the past 13 years, Ansell's highest Days Payable was 91.39. The lowest was 70.61. And the median was 77.01.
FRA:PD1's Days Payable is ranked better than 61.13% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:PD1: 91.39
Ansell's Days Payable
increased
from Dec. 2024 (77.81) to Dec. 2025 (83.72).
It may suggest that Anselldelayed paying its suppliers.
Ansell Days Payable Related Terms
Ansell Days Payable Historical Data
* Premium members only.
The historical data trend for Ansell's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PD1 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Ansell's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ansell Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ansell's Days Payable distribution charts can be found below:
* The bar in red indicates where Ansell's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ansell's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ansell (FRA:PD1) has a Days Payable of 83.72 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ansell and its competitors. This is near median its historical median of 77.01. Over the past decade, Ansell's Days Payable has ranged from 70.61 to 91.39. According to the industry distribution chart, Ansell ranks #309 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 38.9%.
Is Ansell's Days Payable too high?
Ansell's current Days Payable of 83.72 is near median its 10-year median of 77.01. Over the past 10 years, this metric has ranged from a low of 70.61 to a high of 91.39. The Medical Devices & Instruments industry median Days Payable is 68.07. Ansell's value of 83.72 is 23% above this industry median. Based on the distribution chart, Ansell ranks #309 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ansell has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Ansell's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ansell ranks #309 out of 795 companies for Days Payable. This puts Ansell in the upper half of its industry. The industry median Days Payable is 68.07. Ansell's value of 83.72 is 23% above this benchmark. Historically, Ansell's own Days Payable has ranged from 70.61 to 91.39 over the past decade. While the company's 10-year median is 77.01 vs. the industry median of 68.07, Ansell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ansell's current Days Payable of 83.72 is 23% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ansell and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ansell's current Days Payable is 83.72, which is near median its own 10-year median of 77.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Ansell (FRA:PD1) has a current Days Payable of 83.72. The stock's GF Value™ is €63.91, compared to a current price of €69.00 — trading 8% above its estimated fair value. The current Days Payable is 83.72, which is near median its 10-year median of 77.01 and 23% above the Medical Devices & Instruments industry median of 68.07. Ansell's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ansell (FRA:PD1), the current Days Payable is 83.72 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ansell (FRA:PD1) Overvalued in 2026?
Based on GuruFocus' analysis, Ansell stock appears to be overvalued.
The current stock price of €69.00 is trading 8% above its estimated GF Value™ of €63.91.
Key valuation signals for FRA:PD1:
Days Payable: 83.72 (near median its 10-year median of 77.01)
GF Value™: €63.91 vs. price of €69.00 (8% above fair value)
Industry Position: 23% above the Medical Devices & Instruments median (#309 of 795)
No single metric tells the full story. See the FRA:PD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
76GF Score
Get the complete analysis for FRA:PD1
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PD1 has been successfully added to your 
